BMC Ingredients’ Rhiza mycoprotein cleared for sale in Canada

Health Canada has issued a Letter of No Objection for BMC Ingredients’ Rhiza mycoprotein, permitting the ingredient’s use in Canadian food and beverage products. Rhiza, made from the mycelium of the fungus Neurospora crassa, is marketed as a non‑GMO whole‑food protein that also supplies fibre, zinc, iron and potassium. The company offers two formats – Rhiza Tex for meat and seafood analogues and Rhiza Pro for applications such as smoothies, baked goods and pasta.

The approval follows earlier regulatory clearances: the U.S. Food and Drug Administration granted Rhiza Generally Recognized as Safe status, and Singapore’s Food Agency also approved it for food use. CEO Paul Shapiro said the Canadian letter validates the product’s safety and commercial readiness. BMC Ingredients, formerly The Better Meat Co, plans to scale up fermentation capacity, targeting large‑scale commercial volumes by the second quarter of 2027, including a projected 100‑ton‑per‑month dry‑product output from an Asian contract manufacturer.